2 Stocks that Ark Invest loves for 2021
Let’s take a look at two companies that Wood has her eye on and has recently added to Ark’s large portfolio of funds. 
avatar
Mike Sakuraba graduated with double major of English and Economics. Part time writer, part time investor, full time dad. Mike loves writing about technology, sports, and investing.
2021-02-22 15:05

Investing has always been a world where the masses follow the leaders, whether it is someone like Warren Buffet, who has made billions of dollars off of his value investing strategy, or a visionary like Catherine Wood of Ark Invest. Perhaps no other investing firm is held in higher regard right now as seemingly anything Wood touches turns to investing gold. Part of that is a self-fulfilling prophecy by investors in Ark’s successful investing, or an uncanny ability to understand sectors and companies long before others have even heard of them. As an investor, even if you are just following along with what Ark invests in, you are likely to experience your portfolio grow as everyone else tries to join in on Ark’s success. Let’s take a look at two companies that Wood has her eye on and has recently added to Ark’s large portfolio of funds.

2 Stocks that Ark Invest loves for 2021

Nano Dimension Ltd. (NASDAQ:NNDM): The 3D printing sector has been around for years, but perhaps only recently has it been a popular growth industry for investors to really get involved in. The Israel-based company builds and sells its Dragonfly printers that use Nano Dimension’s patented Lights-out Digital Manufacturing technology that is the only printing platform for electronic circuitry. What does that mean? It means Nano Dimension is able to mass produce things such as circuit boards and semiconductors, which are two crucial components to chip makers. Nano Dimension has been taking advantage of its recent stock price and has held several rounds of direct offerings to raise capital for further research and development. NNDM is planning on applying its printing capabilities to a wide variety of sectors including healthcare, aerospace, defense, research, and automotive and industrial.

Bionano Genomics, Inc. (NASDAQ:BNGO): I have written before about the importance of the genomics industry and how it may shape our healthcare in the future. Apparently Ark is well ahead of us as it has already established a genomics industry ETF called ArkG which has some of the world’s finest genomics and medtech companies in it as holdings. Is Bionano Genomics a part of that fund? Well, no, not yet anyways. Several different Ark investors including Cathie Wood herself have mentioned Bionano as a potential investment in the future, and have raved about its technology and what it can do. Currently ArkG holds Pacific Biosciences of California (NASDAQ:PACB) as its second largest holding, but guess what: Bionano’s Saphyr genome mapping software does things more accurately and cheaper than what PACB can do it for. Genome mapping is at the forefront right now with Bionano getting involved in researching the COVID-19 variants and why some people are more genetically predisposed to seeing milder symptoms. Bionano has already run by over 1,150% over the past 52-weeks, and has graduated from a penny stock to a full-on medtech stock with a $3.6 billion market cap. Investors who want to start a position in BNGO may want to act before Ark does, because once Ark announces it has bought, expect shares of Bionano to shoot through the roof.


Disclaimer: I have no positions in any of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. All information should be independently verified and should not be relied upon for purposes of transacting securities or other investments. See terms for more info.

Rate this article

positive
negative
Published On
2021-02-22 15:05

avatar
About the Author
Mike Sakuraba graduated with double major of English and Economics. Part time writer, part time investor, full time dad. Mike loves writing about technology, sports, and investing.


buy-coffee
You've read 1 article in the last year
..thank you for supporting us and for visiting our site. Unlike many other sites, The Dog of Wall Street is available for everyone to read. Our focus is to provide great content for free. Do you like what we are doing? Buy us a cup coffee. It is the fuel that keeps us going..

Levi Strauss' Bold Gambit: Is the Denim Icon's DTC Shift Enough to Weather the Storm?
Levi Strauss & Co. boasts a strong quarter with direct-to-consumer growth and innovative fashion, but can it navigate the choppy waters of the retail market?
By Alfonso | 4 months ago

Amazon's Bold Counterattack: Introducing the China-Direct Discount Section
As competition heats up, Amazon unveils a daring new strategy to offer unbeatable prices and direct shipping from China.
By Alfonso | 4 months ago

Tesla's Legal Challenges: Facing the Music on Autopilot Misrepresentation
Court ruling intensifies scrutiny on Tesla's self-driving claims.
By Alfonso | 5 months ago

Netflix's Ad-Supported Triumph: A New Era in Streaming
Surpassing 40 million users, Netflix’s ad-supported plan redefines the streaming landscape.
By Alfonso | 5 months ago

Tesla Stock (TSLA): Look Who's Back!
I’m cautiously optimistic but I’m at the point where I need to see it to believe it.
By Mike Sakuraba | 6 months ago

2 Earnings To Pay Attention to Next Week
Since big tech is the theme, you probably know what I have my eyes on for next week.
By Mike Sakuraba | 6 months ago

2 Stocks to Watch Below $10
Here are two stocks that are currently less trading in the single digits that I believe have some relative upside from their current prices.
By Mike Sakuraba | 6 months ago

Looking Ahead to Tesla's Earnings: What Can We Expect?
Is there any stock that has been more talked about than Tesla (NASDAQ: TSLA) as of late? It’s a company that is always in the spotlight but the stock is under some heavy scrutiny this year and deservedly so.
By Mike Sakuraba | 6 months ago